Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 164

1.

Lower extremity arterial disease in patients with diabetes: a contemporary narrative review.

Nativel M, Potier L, Alexandre L, Baillet-Blanco L, Ducasse E, Velho G, Marre M, Roussel R, Rigalleau V, Mohammedi K.

Cardiovasc Diabetol. 2018 Oct 23;17(1):138. doi: 10.1186/s12933-018-0781-1. Review.

2.

Comment on Andersen et al. Risk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark. Diabetes Care 2018;41:1955-1962.

Rigalleau V, Lecocq M, Rigo M, Monlun M, Poupon P, Blanco L, Alexandre L, Haissaguerre M, Mohammedi K.

Diabetes Care. 2018 Nov;41(11):e147. doi: 10.2337/dc18-1543. No abstract available.

PMID:
30348848
3.

Lactic Acidosis, Metformin Use, and Dose-Response Association.

Mohammedi K, Blanco L, Rigalleau V.

JAMA Intern Med. 2018 Oct 1;178(10):1429. doi: 10.1001/jamainternmed.2018.4451. No abstract available.

PMID:
30285134
4.

The effects of periodontal treatment on diabetic patients: The DIAPERIO randomized controlled trial.

Vergnes JN, Canceill T, Vinel A, Laurencin-Dalicieux S, Maupas-Schwalm F, Blasco-Baqué V, Hanaire H, Arrivé E, Rigalleau V, Nabet C, Sixou M, Gourdy P, Monsarrat P; DIAPERIO Group.

J Clin Periodontol. 2018 Oct;45(10):1150-1163. doi: 10.1111/jcpe.13003. Epub 2018 Sep 14.

PMID:
30136741
5.

Longitudinal trends in HbA1c in diabetes: Stable means can hide meaningful long-term changes.

Rigalleau V, Benoit J, Charret L, Bertrand C, Foussard N, Blanco L, Alexandre L, Monlun M, Mohammedi K.

Diabetes Metab Res Rev. 2018 Nov;34(8):e3065. doi: 10.1002/dmrr.3065. Epub 2018 Sep 14. No abstract available.

PMID:
30123984
6.

Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes.

Nativel M, Schneider F, Saulnier PJ, Gand E, Ragot S, Meilhac O, Rondeau P, Burillo E, Cournot M, Potier L, Velho G, Marre M, Roussel R, Rigalleau V, Mohammedi K, Hadjadj S.

Diabetes Care. 2018 Oct;41(10):2162-2169. doi: 10.2337/dc18-0695. Epub 2018 Aug 2.

PMID:
30072406
7.

Comment on Gordin et al. Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes. Diabetes Care 2018;41:815-822.

Azar M, Coirier E, Delyfer MN, Korobelnik JF, Mohammedi K, Blanco L, Alexandre L, Monlun M, Rigalleau V.

Diabetes Care. 2018 Jul;41(7):e127. doi: 10.2337/dc18-0510. No abstract available.

PMID:
29934488
8.

Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.

Blanc-Bisson C, Velayoudom-Cephise FL, Cougnard-Gregoire A, Helmer C, Rajaobelina K, Delcourt C, Alexandre L, Blanco L, Mohammedi K, Monlun M, Rigalleau V.

Cardiovasc Diabetol. 2018 Jun 8;17(1):82. doi: 10.1186/s12933-018-0718-8.

9.

Nerve action potential amplitude, a robust marker of diabetic peripheral neuropathy.

Monlun M, Hugo M, Blanco L, Mohammedi K, Ahdab R, Alexandre L, Poirot-Mazeres S, Rajaobelina K, Rigalleau V.

Diabet Med. 2018 Oct;35(10):1460-1461. doi: 10.1111/dme.13690. No abstract available.

PMID:
29791761
10.

Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120-127.

Foussard N, Cougnard-Gregoire A, Rajaobelina K, Delcourt C, Helmer C, Lamireau T, Blanco L, Alexandre L, Mohammedi K, Rigalleau V.

Diabetes Care. 2018 Jun;41(6):e101. doi: 10.2337/dc18-0069. No abstract available.

PMID:
29784705
11.

Early Weight Gain in Pregnancy and Infant Birth Weight: May Early Blood Glucose Level Play a Role?

Rigalleau V, Cambos S, Blanco L.

JAMA Pediatr. 2018 Jun 1;172(6):598. doi: 10.1001/jamapediatrics.2018.0413. No abstract available.

PMID:
29710073
12.

No prognostic role of a GWAS-derived genetic risk score in renal outcomes for patients from French cohorts with type 1 and type 2 diabetes.

Barbieux P, György B, Gand E, Saulnier PJ, Ducrocq G, Halimi JM, Feigerlova E, Hulin-Delmotte C, Llaty P, Montaigne D, Rigalleau V, Roussel R, Sosner P, Zaoui P, Ragot S, Marre M, Tregouët DA, Hadjadj S; SURDIAGENE Study Group; French JDRF Diabetic Nephropathy Collaborative Research Initiative (Search for genes determining time to onset of ESRD in T1D patients with proteinuria).

Diabetes Metab. 2018 Feb 10. pii: S1262-3636(18)30038-7. doi: 10.1016/j.diabet.2018.01.016. [Epub ahead of print] No abstract available.

PMID:
29540294
13.

A Medically Supervised Pregnancy Exercise Intervention in Obese Women: A Randomized Controlled Trial.

Cambos S, Rigalleau V, Blanco L.

Obstet Gynecol. 2018 Mar;131(3):599. doi: 10.1097/AOG.0000000000002505. No abstract available.

PMID:
29470327
14.

Comment on Jaiswal et al. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care 2017;40:1226-1232.

Simoneau A, Monlun M, Poupon P, Baillet-Blanco L, Alexandre L, Mohammedi K, Rigalleau V.

Diabetes Care. 2018 Mar;41(3):e35-e36. doi: 10.2337/dc17-2175. No abstract available.

PMID:
29463673
15.

Autofluorescence of Skin Advanced Glycation End Products as a Risk Factor for Open Angle Glaucoma: The ALIENOR Study.

Schweitzer C, Cougnard-Gregoire A, Rigalleau V, Dartigues JF, Malet F, Rougier MB, Delyfer MN, Helmer C, Korobelnik JF, Delcourt C.

Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):75-84. doi: 10.1167/iovs.17-22316.

PMID:
29332119
16.

Predictors of early renal function decline in Type 1 diabetes: retinopathy.

Monlun M, Blanco L, Alexandre L, Mohammedi K, Rigalleau V.

Diabet Med. 2018 Feb;35(2):281-283. doi: 10.1111/dme.13558. No abstract available.

PMID:
29193321
17.

Physical activity levels of patients with type 2 diabetes in hospital and at home.

Pupier E, Fagour C, Tavitian M, Pezzino S, Rigalleau V.

Acta Diabetol. 2018 Jan;55(1):107-109. doi: 10.1007/s00592-017-1067-x. Epub 2017 Nov 9. No abstract available.

PMID:
29119249
18.

Accumulation of advanced glycation end products evaluated by skin autofluorescence and incident frailty in older adults from the Bordeaux Three-City cohort.

Pilleron S, Rajaobelina K, Tabue Teguo M, Dartigues JF, Helmer C, Delcourt C, Rigalleau V, Féart C.

PLoS One. 2017 Oct 17;12(10):e0186087. doi: 10.1371/journal.pone.0186087. eCollection 2017.

19.

Sudomotor function in diabetic peripheral artery disease: a role for diabetic neuropathy?

Poupon P, Monlun M, Alexandre L, Blanco L, Rigalleau V.

Neurol Sci. 2018 Jan;39(1):191-192. doi: 10.1007/s10072-017-3103-6. Epub 2017 Sep 15. No abstract available.

PMID:
28914379
20.

Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious?

Rigalleau V, Blanco L, Alexandre L, Pupier E, Lasseur C, Barthe N, Combe C.

Diabetologia. 2017 Oct;60(10):2121-2122. doi: 10.1007/s00125-017-4378-0. Epub 2017 Jul 19. No abstract available.

PMID:
28725913

Supplemental Content

Loading ...
Support Center